The phrase 'development of a disease' is correct and usable in written English.
You can use it whenever you are referring to the process of a disease developing or progressing. For example: "The development of a disease can be difficult to predict and control."
Then after they were exposed, they were taken to the labs, where we would test their blood and monitor the development of a disease in them.
In the development of a disease (pathogenesis) more is involved than merely exposure to a causative agent.
Researchers must be sure that exposure to the suspected cause precedes the development of a disease; that there is a high degree of correlation between the two; that findings are replicated in different studies in various settings; that a biological explanation exists that makes the association plausible; and that increased exposure makes development of the disease more likely.
Overall, quantifying the changes in the calcium signaling pathway in db/db diabetic beta-cells will aid in the development of a disease model that could provide insight into the adaptive transformations of beta-cell function during diabetes development.
On the other hand, the elevated expression variation was measured prior to development of a disease – hence it may be causative to the subsequent pathogenesis.
Certain pro-inflammatory plasma proteins are used as diagnostic biomarkers for disease state but specific plasma proteins may also be used as biomarkers for early state in the development of a disease.
Here we report the development of a disease-specific quality of life score questionnaire for patients with neuroendocrine tumours of the gut to supplement the EORTC core cancer questionnaire, the QLQ-C30.
We suggest that an important step forward in this field of research would be made with the development of a disease-specific QoL instrument for BD.
If however, the structure in causal relationships between factors predictive of disability differs from other populations, the development of a disease-specific theoretical framework will be essential.
The international expert group identified tuberculosis and meningococcal disease as the two infectious diseases with the highest priority for the development of a disease-specific risk assessment tool.
